机译:Regional infusion of a class C TLR9 agonist enhances liver tumor microenvironment reprogramming and MDSC reduction to improve responsiveness to systemic checkpoint inhibition
Roger Williams Medical Center,Immuno-oncology Institute;
TriSalus? Life Sciences, Inc.;